Spinal Cord InjuryDRIVNCT07473258
DRIV - Health Online for People With Spinal Cord Injury
A study testing DRIV Program in people with Spinal Cord Injury, run by Karolinska Institutet at 1 site in Sweden.
Trial summary
The goal of this clinical trial is to learn if a 10-week web-based health promotion program ("DRIV") can improve healthy lifestyle habits and overall well-being in adults living with long-term spinal cord injury (SCI). Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Spinal Cord Injury
- What is being tested?
- DRIV Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteSweden
- Study dates
- 1 Aug 2025to 30 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults (18 years or older) living with a long-term spinal cord injury (acquired or congenital) and "aging with the injury" (i.e., have lived many years with SCI).
- Have registered interest in participating in the 10-week web-based health promotion program "DRIV - hälsa online för dig med ryggmärgsskada" (health online for people with SCI).
- Able to provide informed consent and complete self-assessment questionnaires (no severe cognitive impairment that would hinder participation).
- Sufficient Swedish language skills and internet access to participate in weekly online group sessions via video.
Who cannot join
- Individuals with severe psychiatric conditions that would interfere with active participation in a group health program (unmanaged mental illness preventing engagement in the online sessions).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: DRIV - Health Online for People With a Spinal Cord Injury
The goal of this clinical trial is to learn if a 10-week web-based health promotion program ("DRIV") can improve healthy lifestyle habits and overall well-being in adults living with long-term spinal cord injury (SCI). The main questions it aims to answer are:
Does participating in the online course lead to healthier lifestyle behaviors (for example, more physical activity and a better diet) and improved self-reported health for people with SCI? Are any improvements in health habits or well-being maintained six months after completing the program?
Read more
Researchers will compare participants who take the 10-week DRIV course to those on a waitlist (no intervention during that period) to see if any changes in lifestyle or health outcomes are due to the program (and not just time or other factors).
Participants will:
Attend a 1-hour group session online (via video) each week for 10 weeks, covering topics like exercise, nutrition, stress management, and goal setting (this is the intervention for the course group; waitlist group has no sessions during this time).
Complete health questionnaires at the start of the study and after 10 weeks (all participants), and again 6 months after the course for those who received the intervention, to report on their lifestyle habits, physical and mental health, and goal achievement.
Wear a wrist activity monitor (accelerometer) for 7 days at the beginning and 7 days at the end of the 10-week period to objectively measure physical activity levels.
Read the detailed description
Overview This study evaluates the DRIV program, a 10-week web-based health-promotion course designed for individuals living long-term with spinal cord injury (SCI). The Detailed Description below outlines the study's operational procedures, design, data-collection flow, and analytic approach. It intentionally avoids content already provided in sections such as background, significance, eligibility criteria, and outcome measures.
Study Design The study uses a prospective intervention design with a waitlist control group. All individuals who register for the DRIV course are placed on a waitlist. For each course cycle, 8-12 individuals are invited to participate in that round and make up the intervention cohort. Individuals remaining on the waitlist are invited to serve as controls, with the guarantee that they will later be offered participation in a future course cycle.
Participants are not blinded to their group assignment, as the intervention consists of an educational course requiring active engagement.
Intervention Procedures
The intervention is the 10-week DRIV online course, delivered via Zoom. Each weekly session includes:
A topic-specific lecture (e.g., adapted physical activity, nutrition, stress management).
Facilitated discussions based on a study-circle model. Structured goal-setting and behavioral-change strategies. Weekly home assignments and optional adapted exercise sessions.
All course participants (regardless of research participation) receive identical program content. Study participants additionally complete standardized assessments at specified timepoints.
Control Procedures Control participants receive no intervention during their 10-week control period and continue their usual activities. They complete the same baseline and 10-week assessments as the intervention group, allowing comparison of changes over an equivalent time frame. Once their control period ends, they are offered a place in the next DRIV course but are not included again as new study controls.
Measurement Schedule
Study participants complete assessments at the following timepoints:
- T1 (Baseline): Prior to course start (or at the equivalent time for controls).
- T2 (10 weeks): Immediately after the intervention period (or after 10 weeks on the waitlist for controls).
- T3 (6-month follow-up): Six months after course completion (intervention group only).
All assessments are self-administered digitally via REDCap. Participants in both groups wear an accelerometer for 7 days at T1 and T2; only intervention participants repeat this at T3.
Data Collection Procedures
- Survey invitations are distributed individually by email with unique coded links.
- Participants self-measure height, weight, and waist circumference using standardized written instructions.
- Accelerometers are mailed to participants with instructions and returned for data upload.
- All questionnaire and accelerometer data are automatically labeled with the participant's study code.
No identifiable data are stored within the analytic dataset. The code key linking identities to study codes is stored separately by the PI in secure, locked storage.
Data Management Coded data from REDCap and accelerometers are exported to a secure institutional OneDrive project folder. Only authorized research team members have access. Data integrity is monitored through routine checks for completeness, timestamp accuracy, and device-return compliance. Any discrepancies are documented and resolved prior to analysis.
Statistical Approach
Data analysis will follow these steps:
- Descriptive analyses Summaries of baseline characteristics and distribution checks for all continuous and categorical variables.
- Within-group analyses Change over time within the intervention group (T1→T2 and T1→T3) using appropriate paired methods depending on variable type and distribution.
- Between-group comparison at 10 weeks Comparison of change from T1→T2 between intervention and control participants to distinguish intervention-related effects from natural variation.
Exploratory analyses
- Associations between baseline characteristics and degree of change. Relationships between changes in different domains (e.g., self-efficacy vs. physical activity). Sensitivity analyses for missing data or partial adherence.
- Analyses are primarily exploratory due to the multifactorial outcome structure and modest sample size.
Sample Size Considerations The study aims to recruit approximately 30 intervention participants and 30 controls across multiple course iterations. This sample size is considered feasible and adequate for detecting meaningful changes in key behavioral and psychosocial measures based on effect sizes reported in previous SCI health-behavior studies. Recruitment continues until target numbers are achieved.
Participant Flow and Adherence Tracking Adherence to program components (session attendance, assignment completion) is recorded through weekly logs maintained by the course leader. Completion of T1-T2-T3 assessments is monitored through REDCap timestamps. Dropout or non-completion is documented with reason if provided.
Ethical and Data-Protection Procedures
All participants provide written informed consent prior to data collection. The intervention is voluntary and declining research participation does not restrict course participation.
All handling of personal data complies with GDPR and institutional policies. Risks are minimal, limited to potential discomfort reflecting on lifestyle habits or wearing an activity monitor.
- Conditions
- Spinal Cord Injury
- Being tested
- DRIV Program
- Keywords
- clinical trial
- Medical subject headings
- Spinal Cord Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DRIV ProgramBehavioural
Also called Arm 1 Intervention
Participants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions.
| Study group | Role | What they receive |
|---|---|---|
| Arm 1: Intervention - DRIV Program | Experimental | Participants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions. Receives: Behavioral: DRIV Program |
| Arm 2: Waitlist Control | No intervention | Participants assigned to the waitlist control group do not receive the DRIV program during the initial 10-week study period. They continue their usual routines and complete the same assessments as the intervention group at baseline and after 10 weeks. After finishing their role as controls, they are offered participation in the DRIV program during the next available course cycle (but are not reassigned as study participants). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Physical Activity (measured by wrist-worn accelerometer)
Physical activity intensity and duration measured using a 7-day wrist accelerometer at baseline and after the 10-week intervention. Values will be summarized as average daily minutes of moderate-to-vigorous physical activity.nt is conducted six months after the program to evaluate sustained effects.
Measured: Baseline to 10 weeks
Change in Self-Reported Lifestyle Behaviors (using standardized lifestyle questionnaire)
Self-reported changes in diet, physical activity, sleep, stress, and tobacco/alcohol use using national public-health lifestyle indicator questions. Scores will be summarized as change from baseline.
Measured: Baseline to 10 weeks
Change in Well-Being (using the International SCI Quality of Life Basic Dataset)
Self-reported satisfaction with general well-being, physical health, and psychological health on a 0-10 scale. Higher scores indicate better well-being. Reported as the change from baseline.
Measured: Baseline to 10 weeks
Maintenance of Lifestyle and Well-Being Improvements at 6 Months
Sustained change in lifestyle behaviors and well-being at 6-month follow-up using the same questionnaires as above.
Measured: 10 weeks to 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Mar 2026
- Study start1 Aug 2025
- Primary completion30 Dec 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal Cord InjuryStudies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Participants are allocated to one of two non-randomized parallel groups. Individuals invited to participate in the immediate 10-week DRIV online health-promotion program form the intervention group. Individuals who remain on the waitlist and do not receive any intervention during the same 10-week period form the waitlist control group. After completing the control period and follow-up assessments, waitlist participants are offered the DRIV program. This design allows comparison between the intervention and control groups over an equivalent 10-week timeframe.
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tobias Holmlund, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07473258
- Sponsor's protocol ID
- 2023-01754-01
- Other IDs
- 2023
- Acronym
- DRIV
- Status last verified
- Apr 2026
- First submitted
- 17 Nov 2025
- Last updated
- 20 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual Participant Data (IPD) will not be shared because the study involves a small and specific population-adults living with long-term spinal cord injury-making it difficult to fully anonymize the data. Sharing IPD could risk compromising participant confidentiality, especially given the sensitive nature of health-related information and the group-based format of the intervention. Additionally, the study was not designed with external data sharing in mind, and participants were not asked to consent to such sharing.
Study at a glance
From the registry record, last updated by the sponsor on 20 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- DRIV - Health Online for People With a Spinal Cord Injury
- ClinicalTrials.gov ID
- NCT07473258
- Acronym / sponsor ID
- DRIV / 2023-01754-01
- Conditions
- Spinal Cord Injury
- Keywords
- clinical trial
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 16 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a 10-week web-based health promotion program ("DRIV") can improve healthy lifestyle habits and overall well-being in adults living with long-term spinal cord injury (SCI). The main questions it aims to answer are:
Does participating in the online course lead to healthier lifestyle behaviors (for example, more physical activity and a better diet) and improved self-reported health for people with SCI? Are any improvements in health habits or well-being maintained six months after completing the program?
Researchers will compare participants who take the 10-week DRIV course to those on a waitlist (no intervention during that period) to see if any changes in lifestyle or health outcomes are due to the program (and not just time or other factors).
Participants will:
Attend a 1-hour group session online (via video) each week for 10 weeks, covering topics like exercise, nutrition, stress management, and goal setting (this is the intervention for the course group; waitlist group has no sessions during this time).
Complete health questionnaires at the start of the study and after 10 weeks (all participants), and again 6 months after the course for those who received the intervention, to report on their lifestyle habits, physical and mental health, and goal achievement.
Wear a wrist activity monitor (accelerometer) for 7 days at the beginning and 7 days at the end of the 10-week period to objectively measure physical activity levels.
Detailed description
Overview This study evaluates the DRIV program, a 10-week web-based health-promotion course designed for individuals living long-term with spinal cord injury (SCI). The Detailed Description below outlines the study's operational procedures, design, data-collection flow, and analytic approach. It intentionally avoids content already provided in sections such as background, significance, eligibility criteria, and outcome measures.
Study Design The study uses a prospective intervention design with a waitlist control group. All individuals who register for the DRIV course are placed on a waitlist. For each course cycle, 8-12 individuals are invited to participate in that round and make up the intervention cohort. Individuals remaining on the waitlist are invited to serve as controls, with the guarantee that they will later be offered participation in a future course cycle.
Participants are not blinded to their group assignment, as the intervention consists of an educational course requiring active engagement.
Intervention Procedures
The intervention is the 10-week DRIV online course, delivered via Zoom. Each weekly session includes:
A topic-specific lecture (e.g., adapted physical activity, nutrition, stress management).
Facilitated discussions based on a study-circle model. Structured goal-setting and behavioral-change strategies. Weekly home assignments and optional adapted exercise sessions.
All course participants (regardless of research participation) receive identical program content. Study participants additionally complete standardized assessments at specified timepoints.
Control Procedures Control participants receive no intervention during their 10-week control period and continue their usual activities. They complete the same baseline and 10-week assessments as the intervention group, allowing comparison of changes over an equivalent time frame. Once their control period ends, they are offered a place in the next DRIV course but are not included again as new study controls.
Measurement Schedule
Study participants complete assessments at the following timepoints:
- T1 (Baseline): Prior to course start (or at the equivalent time for controls).
- T2 (10 weeks): Immediately after the intervention period (or after 10 weeks on the waitlist for controls).
- T3 (6-month follow-up): Six months after course completion (intervention group only).
All assessments are self-administered digitally via REDCap. Participants in both groups wear an accelerometer for 7 days at T1 and T2; only intervention participants repeat this at T3.
Data Collection Procedures
- Survey invitations are distributed individually by email with unique coded links.
- Participants self-measure height, weight, and waist circumference using standardized written instructions.
- Accelerometers are mailed to participants with instructions and returned for data upload.
- All questionnaire and accelerometer data are automatically labeled with the participant's study code.
No identifiable data are stored within the analytic dataset. The code key linking identities to study codes is stored separately by the PI in secure, locked storage.
Data Management Coded data from REDCap and accelerometers are exported to a secure institutional OneDrive project folder. Only authorized research team members have access. Data integrity is monitored through routine checks for completeness, timestamp accuracy, and device-return compliance. Any discrepancies are documented and resolved prior to analysis.
Statistical Approach
Data analysis will follow these steps:
- Descriptive analyses Summaries of baseline characteristics and distribution checks for all continuous and categorical variables.
- Within-group analyses Change over time within the intervention group (T1→T2 and T1→T3) using appropriate paired methods depending on variable type and distribution.
- Between-group comparison at 10 weeks Comparison of change from T1→T2 between intervention and control participants to distinguish intervention-related effects from natural variation.
Exploratory analyses
- Associations between baseline characteristics and degree of change. Relationships between changes in different domains (e.g., self-efficacy vs. physical activity). Sensitivity analyses for missing data or partial adherence.
- Analyses are primarily exploratory due to the multifactorial outcome structure and modest sample size.
Sample Size Considerations The study aims to recruit approximately 30 intervention participants and 30 controls across multiple course iterations. This sample size is considered feasible and adequate for detecting meaningful changes in key behavioral and psychosocial measures based on effect sizes reported in previous SCI health-behavior studies. Recruitment continues until target numbers are achieved.
Participant Flow and Adherence Tracking Adherence to program components (session attendance, assignment completion) is recorded through weekly logs maintained by the course leader. Completion of T1-T2-T3 assessments is monitored through REDCap timestamps. Dropout or non-completion is documented with reason if provided.
Ethical and Data-Protection Procedures
All participants provide written informed consent prior to data collection. The intervention is voluntary and declining research participation does not restrict course participation.
All handling of personal data complies with GDPR and institutional policies. Risks are minimal, limited to potential discomfort reflecting on lifestyle habits or wearing an activity monitor.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants are allocated to one of two non-randomized parallel groups. Individuals invited to participate in the immediate 10-week DRIV online health-promotion program form the intervention group. Individuals who remain on the waitlist and do not receive any intervention during the same 10-week period form the waitlist control group. After completing the control period and follow-up assessments, waitlist participants are offered the DRIV program. This design allows comparison between the intervention and control groups over an equivalent 10-week timeframe.
| Arm | Type | Receives |
|---|---|---|
| Arm 1: Intervention - DRIV Program | Experimental | Behavioral: DRIV ProgramParticipants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions. |
| Arm 2: Waitlist Control | No intervention | –Participants assigned to the waitlist control group do not receive the DRIV program during the initial 10-week study period. They continue their usual routines and complete the same assessments as the intervention group at baseline and after 10 weeks. After finishing their role as controls, they are offered participation in the DRIV program during the next available course cycle (but are not reassigned as study participants). |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adults (18 years or older) living with a long-term spinal cord injury (acquired or congenital) and "aging with the injury" (i.e., have lived many years with SCI).
- Have registered interest in participating in the 10-week web-based health promotion program "DRIV - hälsa online för dig med ryggmärgsskada" (health online for people with SCI).
- Able to provide informed consent and complete self-assessment questionnaires (no severe cognitive impairment that would hinder participation).
- Sufficient Swedish language skills and internet access to participate in weekly online group sessions via video.
Key exclusion criteria (1 listed)
- Individuals with severe psychiatric conditions that would interfere with active participation in a group health program (unmanaged mental illness preventing engagement in the online sessions).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DRIV ProgramAlso: Arm 1 InterventionParticipants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions. | Behavioural | Arm 1: Intervention - DRIV Program |
Primary outcome
Change in Physical Activity (measured by wrist-worn accelerometer)
Time frame: Baseline to 10 weeks
Physical activity intensity and duration measured using a 7-day wrist accelerometer at baseline and after the 10-week intervention. Values will be summarized as average daily minutes of moderate-to-vigorous physical activity.nt is conducted six months after the program to evaluate sustained effects.
Change in Self-Reported Lifestyle Behaviors (using standardized lifestyle questionnaire)
Time frame: Baseline to 10 weeks
Self-reported changes in diet, physical activity, sleep, stress, and tobacco/alcohol use using national public-health lifestyle indicator questions. Scores will be summarized as change from baseline.
Change in Well-Being (using the International SCI Quality of Life Basic Dataset)
Time frame: Baseline to 10 weeks
Self-reported satisfaction with general well-being, physical health, and psychological health on a 0-10 scale. Higher scores indicate better well-being. Reported as the change from baseline.
Maintenance of Lifestyle and Well-Being Improvements at 6 Months
Time frame: 10 weeks to 6 months
Sustained change in lifestyle behaviors and well-being at 6-month follow-up using the same questionnaires as above.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Apr 2026.
- the homepage for the projectLink provided by the sponsor.
- Individual participant dataSharing planned: No. Individual Participant Data (IPD) will not be shared because the study involves a small and specific population-adults living with long-term spinal cord injury-making it difficult to fully anonymize the data. Sharing IPD could risk compromising participant confidentiality, especially given the sensitive nature of health-related information and the group-based format of the intervention. Additionally, the study was not designed with external data sharing in mind, and participants were not asked to consent to such sharing.
Related trials for Spinal Cord Injury
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Clinical Outcome Assessment for AT & BCI
Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI
Spinal Cord Injuries
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
Chronic Spinal Cord Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing DRIV Program in people with Spinal Cord Injury, run by Karolinska Institutet at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Physical Activity (measured by wrist-worn accelerometer) (time frame: Baseline to 10 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.